BUZZ-Moderna gains after receiving COVID-19 vaccine supply tender

** Shares of vaccine maker Moderna MRNA.O gain 1.9% to $43.18 premarket

** Co has been awarded tender to supply its mRNA COVID-19 vaccine in the European Union, Norway and North Macedonia, allowing 17 countries to access the vaccine for up to four years

** Tender comes after MRNA cut its 2025 sales forecast by $1 bln earlier this month, partially due to weak demand for its COVID-19 vaccines

** The trim brought co's FY25 revenue forecast below analysts' estimates and sent shares down nearly 17% on Jan. 13

** Seven of 26 brokerages covering stock rate it "buy", 15 rate "hold" and four rate "sell" or lower; median PT is $57 - LSEG data

** MRNA stock more than halved in 2024